SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-130675
Filing Date
2021-10-28
Accepted
2021-10-28 06:40:29
Documents
17
Period of Report
2021-10-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131077d1_8k.htm   iXBRL 8-K 34880
2 EXHIBIT 99.1 tm2131077d1_ex99-1.htm EX-99.1 539799
3 EXHIBIT 99.2 tm2131077d1_ex99-2.htm EX-99.2 905459
8 GRAPHIC tm2131077d1_ex99-1img0001.jpg GRAPHIC 13136
9 GRAPHIC tm2131077d1_ex99-1img0002.jpg GRAPHIC 15090
  Complete submission text file 0001104659-21-130675.txt   1827469

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrk-20211028.xsd EX-101.SCH 4294
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20211028_def.xml EX-101.DEF 28352
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20211028_lab.xml EX-101.LAB 38468
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20211028_pre.xml EX-101.PRE 26965
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2131077d1_8k_htm.xml XML 7856
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 211354967
SIC: 2834 Pharmaceutical Preparations